An Israeli company has approval to start muscle regeneration trails in Germany for hip replacement surgery.
“This is an important new indication for PLX cells, as beyond potentially showing safety and efficacy in muscle regeneration after hip replacement surgery, this opens PLX cells to the possibility of addressing large new markets in sports injury treatment and muscular regenerative medicine," said Zami Aberman, Chairman and CEO of Pluristem. "We are very pleased with the growing number of new indications and new clinical trials currently initiated for our PLX cells around the world.”
I dont understand why allogenic stem cells trials are being sought for hip replacement surgeries, and sports injuries. This should be working for Duchenne too. I have written to the contacts given for the company and will keep everyone posted on their replies.
A formal connect from PPMD may elicit a much more prompt and detailed response.
@ Sharon, any thoughts on chasing this one.